Related Experiment Videos
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation
R Chiesa1, P Piccardo, B Ghetti
1Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract:
Familial prion diseases are caused by mutations in the gene encoding the prion protein (PrP). We have produced transgenic mice that express the mouse homolog of a mutant human PrP containing a nine octapeptide insertion associated with prion dementia. These mice exhibit a slowly progressive neurological disorder characterized clinically by ataxia and neuropathologically by cerebellar atrophy and granule cell loss, gliosis, and PrP deposition that is most prominent in the cerebellum and hippocampus. Mutant PrP molecules expressed in the brains of these mice are resistant to digestion by low concentrations of proteinase K and display several other biochemical properties reminiscent of PrP(Sc), the pathogenic isoform of PrP. These results establish a new transgenic animal model of an inherited human prion disorder.
Insights
Researchers created transgenic mice modeling inherited prion diseases. These mice develop neurological disorders and brain changes similar to human prion dementia, offering a new animal model for study.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Familial prion diseases stem from mutations in the prion protein (PrP) gene.
- Understanding these inherited disorders is crucial for developing effective treatments.
Purpose of the Study:
- To create a new transgenic mouse model for studying inherited human prion diseases.
- To investigate the pathological mechanisms of prion dementia.
Main Methods:
- Produced transgenic mice expressing a mutant human prion protein (PrP) with a nine octapeptide insertion.
- Clinically and neuropathologically characterized the resulting neurological disorder in mice.
- Biochemically analyzed mutant PrP molecules for properties similar to pathogenic PrP(Sc).
Main Results:
- Transgenic mice exhibited progressive ataxia and cerebellar atrophy.
- Neuropathology included granule cell loss, gliosis, and PrP deposition in the cerebellum and hippocampus.
- Mutant PrP in mouse brains showed resistance to proteinase K digestion, similar to PrP(Sc).
Conclusions:
- Successfully established a new transgenic animal model for inherited human prion disorders.
- This model mimics key clinical and pathological features of prion dementia.
- Facilitates further research into the pathogenesis and potential therapies for these diseases.